Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population

Fig. 5

Gastric cancer PDXs respond robustly to lenvatinib. A Growth curves for the vehicle and lenvatinib-treated PDX lines. B Percent change in tumor volume of the vehicle and lenvatinib-treated PDX lines. Each dot represents one mouse. The error bar represents the standard error of the mean. C Vehicle and lenvatinib-treated tumors from PDX Line 1. D Percent change of mouse body weight throughout treatment

Back to article page